0.493

13.54% 0.0588

Actuate Therapeutics Inc (ACTU)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione

Precedente Chiudi:

$0.4342

Aprire:

$0.457

Volume 24 ore:

337.75K

Relative Volume:

0.83

Capitalizzazione di mercato:

$11.84M

Reddito:

Utile/perdita netta:

$-21.54M

Rapporto P/E:

-0.4978

EPS:

-0.9904

Flusso di cassa netto:

$-19.60M

1 W Prestazione:

-27.39%

1M Prestazione:

-49.88%

6M Prestazione:

-77.07%

1 anno Prestazione:

-93.70%

Intervallo 1D:

$0.4326

$0.4987

Intervallo di 1 settimana:

$0.41

$0.6801

Portata 52W:

$0.41

$8.2652

Actuate Therapeutics Inc Stock (ACTU) Company Profile

Nome

Actuate Therapeutics Inc

Settore

Healthcare (1051)

Industria

Biotechnology (593)

Telefono

847-986-4190

Indirizzo

1751 RIVER RUN, FORT WORTH

Dipendente

Cinguettio

Prossima data di guadagno

2026-11-12

Ultimi documenti SEC

ACTU's Discussions on Twitter

Compare ACTU vs VRTX, MRNA, REGN, ARGX, ONC

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ACTU Actuate Therapeutics Inc	0.493	11.84M	0	-21.54M	-19.60M	-0.9904
VRTX Vertex Pharmaceuticals Inc	508.15	128.80B	12.34B	4.34B	3.71B	16.87
MRNA Moderna Inc	238.82	95.35B	2.23B	-3.19B	-1.60B	-8.1462
REGN Regeneron Pharmaceuticals Inc	799.63	82.33B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	851.39	53.54B	4.16B	1.29B	734.26M	19.58
ONC Beone Medicines Ltd Adr	373.90	42.30B	5.76B	514.49M	1.10B	4.4813

Actuate Therapeutics Inc Stock (ACTU) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-08-26	Iniziato	B. Riley Securities	Buy
2025-04-22	Iniziato	Craig Hallum	Buy
2025-03-17	Iniziato	H.C. Wainwright	Buy

Actuate Therapeutics Inc Borsa (ACTU) Ultime notizie

Oct 08, 2026

AbbVie's Temab-A Gets Two FDA Breakthrough Therapy Tags in Cancer - Zacks Investment Research

Oct 08, 2026

Oct 06, 2026

Actuate Therapeutics to sell 50 million shares at assumed $0.819 price - scanx.trade

Oct 06, 2026

Actuate Therapeutics Registers 50 Million Shares for Public Offering at $0.819 Each - Kalkine Media

Oct 06, 2026

At an assumed $0.819 a share, Actuate Therapeutics (Nasdaq: ACTU) proposes a stock offering. - Stock Titan

Oct 06, 2026

Sep 17, 2026

Gyre Therapeutics, Inc.Common Stock (Nasdaq:GYRE) Stock Quote - The Chronicle-Journal

Sep 17, 2026

Sep 09, 2026

Actuate to Present at the H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewswire

Sep 09, 2026

Actuate Therapeutics Reports Synergistic Preclinical Activity of Elraglusib with RAS-Targeted Agents in Pancreatic Cancer Models - Quiver Quantitative

Sep 09, 2026

Actuate to Present at the H.C. Wainwright 28th Annual Global Investment Conference - Yahoo Finance

Sep 09, 2026

Sep 02, 2026

All You Need to Know About Actuate Therapeutics, Inc. (ACTU) Rating Upgrade to Buy - Yahoo Finance

Sep 02, 2026

Aug 21, 2026

12 Health Care Stocks Moving In Thursday's Intraday Session - Sahm

Aug 21, 2026

Aug 20, 2026

Actuate (ACTU) Results Check: EPS Does Not Reach the Reported Estimate under the Current Snapshot; Closing Reaction: The Stock Gains 16.04% for the Current SessionInvestor Earnings Call - vinanet.vn

Aug 20, 2026

12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga

Aug 20, 2026

Actuate (ACTU) Results Review: The EPS Result Is Below Expectation in the Available Record; Share Move: Shares Move 0.95% Up at the CloseRevenue Estimate Trend - vinanet.vn

Aug 20, 2026

Actuate (ACTU) Results Review: The EPS Result Is Below Expectation in the Available Record; Share Move - dars.gov.et

Aug 20, 2026

Actuate (ACTU) Results Review: The EPS Result Is Below Expectation in the Available Record; Share Move - careplusvn.com

Aug 20, 2026

Actuate (ACTU) Results Review: The EPS Result Is Below Expectation in the Available Record; Share Move: Shares Move 0.95% Up at the CloseEarnings Recovery Stocks - dars.gov.et

Aug 20, 2026

Actuate (ACTU) Results Review: The EPS Result Is Below Expectation in the Available Record; Share Move - dars.gov.et

Aug 20, 2026

Actuate (ACTU) Results Review: The EPS Result Is Below Expectation in the Available Record; Share Move: Shares Move 0.95% Up at the CloseSurprise Factor Analysis - dars.gov.et

Aug 20, 2026

Actuate (ACTU) Results Check: EPS Does Not Reach the Reported Estimate under the Current Snapshot; Closing Reaction: The Stock Gains 16.04% for the Current SessionEarnings Revision Downgrade - https://www.dars.gov.et/

Aug 20, 2026

Aug 18, 2026

Actuate Therapeutics (ACTU) Holds $1.00 After 1.31% Gain, Pinned Between Key Support and ResistanceBullish Percent Index - vinanet.vn

Aug 18, 2026

Actuate Therapeutics stock gets FDA clearance for elraglusib trial By Investing.com - Investing.com Canada

Aug 18, 2026

Actuate Therapeutics (ACTU) Holds $1.00 After 1.31% Gain, Pinned Between Key Support and ResistanceInverse ETF Flow - dars.gov.et

Aug 18, 2026

Aug 16, 2026

Actuate Therapeutics (ACTU) Gains 3.58% to $1.01, Approaches Key Resistance at $1.06Bullish Pattern Stocks - vinanet.vn

Aug 16, 2026